#

Novo Nordisk

: 101
Eli Lilly shares hit a record for the first time in more than a year. Are they worth buying?
News·
Eli Lilly shares hit a record for the first time in more than a year. Are they worth buying?
Novo stock jumped after it lost a battle for a med-startup. Whats the upside?
News·
Novo stock jumped after it lost a battle for a med-startup. What's the upside?
Morning in New York: Investors hope for a speedy end to the shutdown
News·
Morning in New York: Investors hope for a speedy end to the shutdown
Lilly and Novo will cut the price of obesity drugs in the US. What will they get in return?
News·
Lilly and Novo will cut the price of obesity drugs in the US. What will they get in return?
Ozempics creator lowered forecasts for the fourth time this year. Should we sell the stock?
News·
Ozempic's creator lowered forecasts for the fourth time this year. Should we sell the stock?
Novo Nordisk and Pfizer raise stakes in battle for weight loss drug developer
News·
Novo Nordisk and Pfizer raise stakes in battle for weight loss drug developer
Pfizer has filed a second lawsuit against Novo. Which company is more attractive to an investor?
News·
Pfizer has filed a second lawsuit against Novo. Which company is more attractive to an investor?
Novo Nordisks 5 challenges: whats at the center of investment banks attention
Review·
Novo Nordisk's 5 challenges: what's at the center of investment banks' attention
Novo Nordisk has entered into a battle with Pfizer over Metsera. Why do they want this biotech startup?
News·
Novo Nordisk has entered into a battle with Pfizer over Metsera. Why do they want this biotech startup?
Canaccord initiates on obesity drugmaker Viking with buy, sees 200% upside
Small Caps·
Canaccord initiates on obesity drugmaker Viking with 'buy,' sees 200% upside
Trump has promised to cut the price of Ozempic to $150. Novo Nordisk and Eli Lilly shares fell
News·
Trump has promised to cut the price of Ozempic to $150. Novo Nordisk and Eli Lilly shares fell
Morning in New York: stock exchanges wait for a signal from consumers
News·
Morning in New York: stock exchanges wait for a signal from consumers
Load more